Growth Metrics

Calidi Biotherapeutics (CLDI) EBITDA (2022 - 2025)

Calidi Biotherapeutics' quarterly EBITDA came in at -$4.4 million in Q4 2025, down 11.36% year-on-year from -$4.9 million in Q4 2024, and up 11.55% quarter-over-quarter from -$4.9 million in Q3 2025.

Calidi Biotherapeutics has reported EBITDA for 4 years, with the latest figure at -$4.4 million in Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 11.36% year-over-year to -$4.4 million; the trailing twelve-month figure through Dec 2025 stood at -$19.9 million (up 7.13% YoY), and the FY2025 full-year result was -$19.9 million, up 7.11% from the prior year.
  • EBITDA for Q4 2025 stood at -$4.4 million, up from -$4.9 million in the prior quarter.
  • The five-year high for EBITDA was -$361622.0 in Q2 2022, with the low at -$9.8 million in Q4 2023.
  • Average EBITDA over 4 years is -$5.2 million, with a median of -$5.3 million recorded in 2023.
  • Year-over-year, EBITDA plunged 1707.69% in 2023 and jumped 60.02% in 2024.
  • Tracing CLDI's EBITDA over 4 years: stood at -$4.7 million in 2022, then plunged by 109.47% to -$9.8 million in 2023, then jumped by 60.02% to -$3.9 million in 2024, then declined by 11.36% to -$4.4 million in 2025.
  • The last three EBITDA figures came in at -$4.4 million (Q4 2025), -$4.9 million (Q3 2025), and -$5.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -13.63 Mn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -14.44 Mn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 1.14 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 661.60 Mn
8 Evaxion A 65.44 Bn 65.42 Bn - -3.82 Mn
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 201.19 Mn
10 Calidi Biotherapeutics - - - -4.37 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -4.37 Mn
Sep 30, 2025 -4.94 Mn
Jun 30, 2025 -5.57 Mn
Mar 31, 2025 -5.06 Mn
Dec 31, 2024 -3.93 Mn
Sep 30, 2024 -5.13 Mn
Jun 30, 2024 -5.67 Mn
Mar 31, 2024 -6.75 Mn
Dec 31, 2023 -9.82 Mn
Sep 30, 2023 -7.22 Mn
Jun 30, 2023 -6.54 Mn
Mar 31, 2023 -5.41 Mn
Dec 31, 2022 -4.69 Mn
Sep 30, 2022 -6.99 Mn
Jun 30, 2022 -361,622.00
Mar 31, 2022 -528,858.00